Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
10.61
+0.34 (3.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for ALHC stock have an average target of 11.88, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 11.97% from the current stock price of 10.61.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ALHC stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Hold | 3 | 3 | 3 | 4 | 4 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold → Buy Upgrades $13 → $17 | Hold → Buy | Upgrades | $13 → $17 | +60.23% | Dec 3, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $10 → $13 | Strong Buy | Maintains | $10 → $13 | +22.53% | Oct 31, 2024 |
| Barclays | Barclays | Sell Maintains $7 → $8 | Sell | Maintains | $7 → $8 | -24.60% | Oct 30, 2024 |
| UBS | UBS | Hold Maintains $9 → $12 | Hold | Maintains | $9 → $12 | +13.10% | Oct 30, 2024 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 11, 2024 |
Financial Forecast
Revenue This Year
2.73B
Revenue Next Year
3.52B
from 2.73B
Increased by 29.24%
EPS This Year
-0.70
from -0.79
EPS Next Year
-0.51
from -0.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.8B | 3.9B | 4.7B | ||
| Avg | 2.7B | 3.5B | 4.3B | ||
| Low | 2.6B | 3.3B | 4.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 42.3% | 33.2% | ||
| Avg | - | 29.2% | 22.5% | ||
| Low | - | 21.3% | 13.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.67 | -0.25 | -0.11 |
| Avg | -0.70 | -0.51 | -0.40 |
| Low | -0.71 | -0.64 | -0.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.